D3 at 4000 IU hits optimal dose perfectly. K2 MK-7 at 120mcg exceeds optimal (100mcg). K2 MK-4 at 500mcg provides additional calcium-directing benefit. The D3+K2 synergy is one of the most evidence-backed combinations in supplementation. CoQ10 at 20mcg is functionally negligible (needs 100mg+) but is just support. Liposomal delivery adds genuine absorption benefit for fat-soluble vitamins.
The set is generated, never written by the brand.
Cymbiotika Cymbiotika Liposomal D3 K2 CoQ10: the formulation holds up. Lead: Vitamin D3 at 4,000 IU. D3 at 4000 IU hits optimal dose perfectly. Clinical dose on the primary, and the panel holds together.
This product aims to support bone health, cardiovascular function, and immune system strength.. The product provides excellent doses of Vitamin D3 and K2 MK-7, both crucial for bone and cardiovascular health, delivered effectively via liposomal technology. However, the inclusion of CoQ10 and K2 MK-4 at negligible doses detracts from the overall formulation, making them essentially inactive ingredients. This mix of strong core ingredients and weak additions results in a good but not outstanding score.
4 of 4 shown, 2 doses at what the trials used
Also on the label (inactive): Purified Water, Organic Glycerin, Phosphatidylcholine, Malic Acid, Citrus Pectin, Konjac Root, Organic Tangerine Oil, Beta Carotene
This read comes from the product's own supplement facts panel. Every dose was cross-referenced with published clinical trials to see whether it matches what the studies actually used.
